OrthoBiologics provides state-of-the-art knowledge of current biologic therapies for a variety of orthopaedic conditions in a single source. The content is presented in a straightforward manner, including defining all currently available orthobiologic options, discussing processing characteristics and appropriate clinical use, and finally, summarizing clinical applications and outcomes as well as future potential directions.In addition to covering current approaches and applications, the editors aim for this book to present "best practices" for those practicing and researching orthopaedic pathologies and orthobiologic treatments, including blood and cellular based therapies. The editors are world-renown experts in the field and this book fills a gap in the market.
- Presents the current state-of-the-art treatments for orthobiologics, including PRP, stem cell therapy, growth factors, scaffolds, and more
- Includes a comprehensive overview of orthobiologics, including definitions, terminology, processing characteristics, clinical outcomes, and more
- Presents current information on the ever-changing regulatory environment
- Provides real-time information on clinical and surgical utilization of orthobiologics
- Written for clinicians, researchers, and students, with content relevant to all those who participate in orthobiologic research and treatment, including orthopaedic surgeons, sports medicine specialists, rheumatologists, physiatrists, and any/all clinicians and researchers with an interest in orthobiologics and regenerative medicine.
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
Dateigröße
ISBN-13
978-0-12-822903-3 (9780128229033)
Schweitzer Klassifikation
1. Autologous blood; platelet-rich plasma and platelet-poor plasma2. Defining, measuring and optimizing platelet-rich plasma3. Optimal use of platelet-rich plasma and plateletpoor plasma4. Where orthobiologics started: what are mesenchymal stem cells?5. Bone marrow-derived mesenchymal stromal cells6. Defining, optimizing, and measuring bone marrow aspirate and bone marrow concentrate7. Optimal clinical use of bone marrow aspirate and bone marrow aspirate concentrate8. Adipose mesenchymal stromal cells9. Defining, optimizing, measuring, and utilizing adipose, MFAT, etc.10. Optimal clinical use of adipose mesenchymalstromal cells11. Basic science and preclinical evidence for amniotic membrane2derived allografts in12. Defining, optimizing, and measuring amniotic/ placental mesenchymal stem cells13. Optimal clinical use of amniotic/placental mesenchymal stem cells14. Synovial mesenchymal stem cells15. Peripheral blood stem cells16. Orthobiologics-growth factors and mediators17. Orthobiologics in the procedure room-who, what, where, when, and how18. Orthobiologics in the operating room-who, what, where, when, and how19. The changing regulatory environment: regulations and restrictions20. Bioscaffolds for osteochondral injuries of the knee21. Orthobiologics on the horizon22. Complications associated with orthobiologics